Supervisin mdica continua por un especialista certificado
Areas typically treated with injectables include the temples, areas around the eyes, the cheeks, lips, and jawline
For microdosing specifically, clinical practitioners report that patients with RA who cannot tolerate or do not qualify for full-dose GLP-1 therapy are seeing meaningful reductions in morning stiffness, flare frequency, and body aches at microdose levels
To identify the treatment cohort, the KRD was searched for all patients with 1 claim for semaglutide 2.4 mg between June 15, 2021 and July 31, 2022
It was through that experience, and the conversations that followed about her skin, that she first learned about GLP-1 medications